Regulation of Biological/Drug Development: An Introduction
Examine preclinical and clinical testing, sources of Good Clinical Practice (GCP) requirements and phases of the clinical trial process. Assess the obligations of sponsors and investigators. Discuss how to interact with FDA. Review compliance and enforcement considerations.
Natasha V. Leskovsek, Partner, Cooley LLP
This session was recorded as part of FDLI’s Virtual Introduction to Biologics and Biosimilars Laws and Regulations Course in March/April 2020.
- +$100 for nonmembers
Virtual Learning FAQ
On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.
On-demand content can be played back on most devices.
If you have concerns, please click the Test Your System link to determine your device’s compatibility, as well as system requirements.
CLE credit is not currently available for pre-recorded sessions.